• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Dexamethasone
    / Rekah


    Active Ingredient
    Dexamethasone 0.5 mg, 2 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Tablets

    30 X 0.5 mg

    full basket chart 715 4091

    Tablets

    50 X 2 mg

    full basket chart 7105 4094

    Related information


    Dosage

    please refer to license holder for full details.


    Indications

    Conditions responding to corticoid therapy.


    Contra-Indications

    Known hypersensitivity, systemic fungal infections, administration of vaccines, including smallpox and rota virus.


    Special Precautions

    The lowest possible dose of corticosteroid should be used. These preparations contain a sulfite preservative which may cause allergic-type reactions. Dietary salt restriction and potassium supplementation may be necessary. Prolonged use may produce posterior subcapsular cataracts and glaucoma. Active tuberculosis. Amebiasis, whether latent or active, should be ruled out. Pregnancy and lactation. Secondary adrenocortical insufficiency may be minimized by the gradual reduction of dosage. Enhanced effect on patients with hypothyroidism and hepatic cirrhosis. Ocular herpes simplex. Psychic derangements may appear when corticosteroids are used. Should be used with caution in non-specific ulcerative colitis.
    See prescribing information for full details.


    Side Effects

    Fluid and electrolyte disturbances. Muscle weakness, steroid myopathy, loss of muscle mass, tendon rupture, osteoporosis, vertebral compression fractures, aseptic necrosis of femoral and humeral heads, pathological fractures of long bones. Peptic ulcer with possible subsequent perforation, pancreatitis, abdominal distension, ulcerative esophagitis. Impaired wound healing, thin fragile skin, petechiae and ecchymoses, facial erythema, increased sweating, suppress reactions to skin tests. Convulsions, increased intracranial pressure with papilledema, vertigo, headache. Menstrual irregularities, development of Cushingoid state, suppression of growth in children, adrenocortical and pituitary unresponsiveness, decreased carbohydrate tolerance, manifestations of latent diabetes mellitus, increased requirements of insulin or oral hypoglycemic agents in diabetics. Negative nitrogen balance, myocardial rupture following recent myocardial infarction.
    See prescribing information for full details.


    Drug interactions

    please refer to license holder for full details.


    Pregnancy and Lactation

    please refer to license holder for full details.


    Overdose

    please refer to license holder for full details.


    Manufacturer
    Rekah Pharmaceutical Prod Ltd.
    CLOSE